日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Comparison of Eight Technologies to Determine Genotype at the UGT1A1 (TA)n Repeat Polymorphism: Potential Clinical Consequences of Genotyping Errors?

比较八种技术确定 UGT1A1 (TA)n 重复多态性基因型:基因分型错误的潜在临床后果?

Tristan M Sissung,Roberto H Barbier,Douglas K Price,Teri M Plona,Kristen M Pike,Stephanie D Mellott,Ryan N Baugher,Gordon R Whiteley,Daniel R Soppet,David Venzon,Arlene Berman,Arun Rajan,Giuseppe Giaccone,Paul Meltzer,William D Figg

Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trial

Cixutumumab 治疗复发或难治性晚期胸腺上皮肿瘤患者:一项多中心、开放标签、2 期临床试验

Arun Rajan, Corey A Carter, Arlene Berman, Liang Cao, Ronan J Kelly, Anish Thomas, Sean Khozin, Ariel Lopez Chavez, Isabella Bergagnini, Barbara Scepura, Eva Szabo, Min-Jung Lee, Jane B Trepel, Sarah K Browne, Lindsey B Rosen, Yunkai Yu, Seth M Steinberg, Helen X Chen, Gregory J Riely, Giuseppe Giac

EGFR and KRAS mutation analysis in cytologic samples of lung adenocarcinoma enabled by laser capture microdissection

利用激光捕获显微切割技术对肺腺癌细胞样本进行 EGFR 和 KRAS 突变分析

Sinchita Roy Chowdhuri, Liqiang Xi, Trinh Hoc-Tran Pham, Jeffrey Hanson, Jaime Rodriguez-Canales, Arlene Berman, Arun Rajan, Giuseppe Giaccone, Michael Emmert-Buck, Mark Raffeld, Armando C Filie

Phase II study of belinostat in patients with recurrent or refractory advanced thymic epithelial tumors

贝利司他治疗复发或难治性晚期胸腺上皮肿瘤患者的 II 期研究

Giuseppe Giaccone, Arun Rajan, Arlene Berman, Ronan J Kelly, Eva Szabo, Ariel Lopez-Chavez, Jane Trepel, Min-Jung Lee, Liang Cao, Igor Espinoza-Delgado, John Spittler, Patrick J Loehrer Sr